ACCLX | VMVIX | ACCLX / VMVIX | |
Total Expense Ratio | 1.98 | 0.19 | 1,042% |
Annual Report Gross Expense Ratio | 1.98 | 0.19 | 1,042% |
Fund Existence | 15 years | 19 years | - |
Gain YTD | 5.502 | 4.674 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.05B | 30.6B | 23% |
Annual Yield % from dividends | 0.65 | 2.14 | 30% |
Returns for 1 year | 1.43 | 8.33 | 17% |
Returns for 3 years | 4.83 | 27.23 | 18% |
Returns for 5 years | 13.23 | 70.36 | 19% |
Returns for 10 years | 4.60 | 92.52 | 5% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 67.29 | 1.21 | +1.83% |
Janus Henderson Global Life Sciences D | |||
RGABX | 74.69 | 0.70 | +0.95% |
American Funds Growth Fund of Amer R2 | |||
MPEGX | 26.55 | N/A | N/A |
Morgan Stanley Inst Discovery I | |||
GSRAX | 11.60 | N/A | N/A |
Goldman Sachs Rising Dividend Gr A | |||
KMDIX | 31.15 | N/A | N/A |
Keeley Gabelli Mid Cap Dividend I |